Survival advantage of the hemochromatosis C282Y mutation

Perspectives in Biology and Medicine

Volumn 51, Issue 1, 2008, Pages 98-102

  Weinberg, Eugene D ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IRON;

ANTIBIOTIC RESISTANCE; CELL GROWTH; CHROMOSOME MUTATION; ESTRUS CYCLE; GEOGRAPHIC DISTRIBUTION; HEMOCHROMATOSIS; HETEROZYGOTE; HUMAN; HYPOTHESIS; IRON INTAKE; MACROPHAGE; MOLECULAR MODEL; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; REVIEW; SALMONELLA TYPHIMURIUM; SURVIVAL; TUBERCULOSIS; TYPHOID FEVER;

BACTERIA; CHROMOSOME ABERRATIONS; HEMOCHROMATOSIS; HETEROZYGOTE; HOMOZYGOTE; HUMANS; IRON; MALE;

MYCOBACTERIUM TUBERCULOSIS; SALMONELLA TYPHI;

EID: 39749121630     PISSN: 00315982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Beutler, E. 2004. Iron absorption in carriers of the C282Y hemochromatosis mutation. Am J Clin Nutr 80:799-800.
2. Bothwell, T. H., and A. P. MacPhail. 1998. Hereditary hemochromatosis: Etiologic, pathologic, and clinical aspects. Sem Hematol 35:55-71.
3. Chlosta, S., et al. 2006. The iron efflux protein ferroportin regulates the intracellular growth of Salmonella enterica. Infec Immun 74:3065-67.
4. Distante, S., et al. 2004. The origin and spread of the HFE-C282Y haemochromatosis mutation. Hum Genet 115:269-79.
5. Hedrick, P. W., and B. C. Verelli. 2006. "Ground truth" for selection on CCR5-Δ32. Trends Genet 22:293-96.
6. Hummel, S., et al. 2005. Detection of the CCR5-Δ32 HIV resistance gene in Bronze Age skeletons. Genes Immun 6:371-74.
7. Hunt, J. R., and H. Zeng. 2004. Iron absorption by heterozygous carriers of the HFE C282Y mutation associated with hemochromatosis. Am J Clin Nutr 80:924-31.
8. Jackson, H. A., et al. 2001. HFE mutations, iron deficiency and overload in 10,500 blood donors. Br J Haematol 114:474-84.
9. Moalem, S., E. D. Weinberg, and M. E. Percy. 2004. Hemochromatosis and the enigma of misplaced iron: Implications of infectious disease and survival. BioMetals 17:135-39.
10. Montosi, G., et al. 2000. Wild-type HFE protein normalizes transferrin iron accumulation in macrophages from subjects with hereditary hemochromatosis. Blood 96:1125-29.
11. Nairz, M., et al. 2007. The co-ordinated regulation of iron homeostasis in murine macrophages limits the availability of iron for intracellular Salmonella typhimurium. Cell Microbiol 9 (in press).
12. Novembre, J., A. P. Galvani, and M. Slatkin,. 2005. The geographic spread of the CCR5 Δ32 HIV resistance allele. PLoS Biol 3:e339.
13. Olakanmi, O., L. S. Schlesinger, and B. E. Britigan. 2007. Hereditary hemochromatosis results in decreased iron acquisition and growth by Mycobacterium tuberculosis within human macrophages. J Leuk Biol 81:195-204.
14. Papanikolaou, G., and K. Pantopoulos. 2005. Iron metabolism and toxicity. Toxicol Appl Pharmacol 202:199-211.
15. Pietrangelo, A. 2006. Molecular insights into the pathogenesis of hereditary haemochromatosis. Gut 55:564-68.
16. Rossi, E., et al. 2001. Effect of hemochromatosis genotype and lifestyle factors on iron and red cell indices in a community population. Clin Chem 47:202-8.
17. Schaible, U. E., et al. 2002. Correction of the iron overload defect in beta-2-microglobulin knockout mice by lactoferrin abolishes their increased susceptibility to tuberculosis. J Exp Med 196:1507-13.
18. Weinberg, E. D. 1998. Patho-ecological implications of microbial acquisition of host iron. Rev Med Microbiol 9:171-78.
19. Weinberg, E. D. 2007. Iron loading in humans: A risk factor for enhanced morbidity and mortality. J Nutr Environ Med 16:43-51.
20. Welsh, M. J., et al. 2001. Cystic fibrosis. In The metabolic and molecular bases of inherited diseases, 8th ed., ed. C. R. Scriver, et al., 5121-88. New York: McGraw-Hill.
21. Whitlock, E. P., et al. 2006. Screening for hereditary hemochromatosis: A systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 145:209-23.